Recommendations for prostate-specific antigen (PSA)-based prostate cancer screening have changed considerably in recent years. In 2008, the US Preventive Services Task Force (USPSTF) recommended against PSA-based prostate cancer screening among men 75 years or older, and in 2012, they recommended against PSA testing for men of all ages. The primary outcome was self-reported PSA testing in the past year for routine reasons. Men who reported a history of or were missing data on prostate cancer diagnosis (n = 1115) or PSA testing (n = 1574) or who had PSA testing for nonscreening reasons (n = 805) were excluded, resulting in an analytic population of 16 196 men. The χ 2 test (α = .05) was used to examine differences in PSA screening rates (SRs). Adjusted screening rate ratios (SRRs) and corresponding 99% confidence intervals (CIs) were estimated using logistic regression models with predicted marginal probabilities and controlled for sociodemographic factors, insurance, and health care characteristics. All analyses were conducted using SAS-callable SUDAAN software, version 9.4, and accounted for the complex survey design.
Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States
Recommendations for prostate-specific antigen (PSA)-based prostate cancer screening have changed considerably in recent years. In 2008, the US Preventive Services Task Force (USPSTF) recommended against PSA-based prostate cancer screening among men 75 years or older, and in 2012, they recommended against PSA testing for men of all ages. 1 Other organizations emphasize shared-decision making for men 50 years or older with a long life expectancy. 2 As a result of shifting recommendations, PSA screening rates declined from 37.8% in 2010 to 30.8% in 2013 among men 50 years or older, resulting in substantial declines in prostate cancer incidence. 3 However, it is not known if PSA testing has continued to decline. The objective of the present study was to examine PSA testing patterns using recently released 2015 National Health Interview Survey (NHIS) data.
Methods | Data on 19 690 male respondents 50 years or older were selected from the 2010, 2013, and 2015 NHIS, an in-person household survey of noninstitutionalized people with respective response rates of 60.8%, 61.2%, and 55.2%. 4 The primary outcome was self-reported PSA testing in the past year for routine reasons. Men who reported a history of or were missing data on prostate cancer diagnosis (n = 1115) or PSA testing (n = 1574) or who had PSA testing for nonscreening reasons (n = 805) were excluded, resulting in an analytic population of 16 196 men. The χ 2 test (α = .05) was used to examine differences in PSA screening rates (SRs). Adjusted screening rate ratios (SRRs) and corresponding 99% confidence intervals (CIs) were estimated using logistic regression models with predicted marginal probabilities and controlled for sociodemographic factors, insurance, and health care characteristics. All analyses were conducted using SAS-callable SUDAAN software, version 9.4, and accounted for the complex survey design.
Results | Of the 16 196 men included in our analyses, more than half were aged 50 to 64 years, and three-quarters had visited their primary care physician in the past year, proportions that were similar across survey years. Among men 50 years or older, unadjusted SRs of PSA testing for routine reasons in the past year decreased from 38.3% in 2010 to 31.5% in 2013 (P < .001) and remained stable at 32.1% through 2015 (P = .62) ( Abbreviations: GED, graduate equivalent degree; HS, high school; NHIS, National Health Interview Survey; PCP, primary care physician; PSA, prostate-specific antigen. a Data on educational attainment were missing for 66 respondents.
b Data on having a usual source of care were missing for 2 respondents.
c Data on visiting a physician in the past year were missing for 10 respondents. Methods | In a patient-level observational study, we included veterans who received primary care from fiscal year 2012 to 2014 and had their medical records abstracted by an independent, external contractor for the External Peer Review Program (n = 422 125). 3 We used External Peer Review Program data for 48 clinical quality measures for chronic disease management and disease prevention that are comparable to Healthcare Effectiveness Data and Information Set measures. We gauged clinic-level PCMH implementation in 2012 for 909 clinics using the PACT implementation Progress Index (Pi 2 ), which includes 8 core components (access, continuity, care coordination, comprehensiveness, self-management support, patient-centered care and communication, shared decision making, and team-based care). 4 We modeled the association Abbreviations: GED, graduate equivalent degree; HS, high school; NHIS, National Health Interview Survey; PSA, prostate-specific antigen; SRR, screening rate ratio. a Model 1 adjusts for race/ethnicity, educational attainment, having a usual source of care, visiting a primary care physician in the past year, insurance type, and US geographic region. Only men with complete data on these factors were included in the model. There were 16 112 men included in the adjusted analysis (2010, n = 4087; 2013, n = 6036; and 2015, n = 5989). b Model 2 includes an interaction term for survey year and age and adjusts for race/ethnicity, educational attainment, having a usual source of care, visiting a primary care physician in the past year, insurance type, and US geographic region. Only men with complete data on these factors were included in the model. There were 16 112 men included in the adjusted analysis (2010, n = 4087; 2013, n = 6036; 2015, n = 5989).
